Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting

Gary A. Croghan, Jeff A Sloan, Ivana T Croghan, Paul Novotny, Richard D. Hurt, Wanda L. DeKrey, James A. Mailliard, Larry P. Ebbert, Debra K. Swan, Daniel J. Walsh, Martin Wiesenfeld, Ralph Levitt, Philip Stella, Patricia A. Johnson, Loren K. Tschetter, Charles Lawrence Loprinzi

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

This multicenter, randomized, open-label clinical trial was conducted to determine whether the combined use of nicotine patch therapy and a nicotine nasal spray would improve smoking abstinence rates compared to either treatment alone, without behavioral counseling. Data were collected at 15 regional cancer control oncology centers within the North Central Cancer Treatment Group. Of the 1384 smokers randomized to the study, 20% were abstinent from smoking at 6 weeks and 8% were abstinent at 6 months. At 6 weeks, the 7-day point prevalence smoking abstinence rate for the patch alone (21.1%) was superior to the spray (13.6%) but was significantly lower than the rate for combination therapy (27.1%). At 6 months, the 7-day point prevalence abstinence rates were not significantly different among the three groups. Combination nicotine nasal spray and nicotine patches were delivered safely in a nonspecialized outpatient clinical setting and enhanced short-term smoking abstinence rates, but these rates were not sustained at 6 months.

Original languageEnglish (US)
Pages (from-to)181-187
Number of pages7
JournalNicotine and Tobacco Research
Volume5
Issue number2
DOIs
StatePublished - Apr 2003

Fingerprint

Tobacco Use Cessation Products
Multicenter Studies
Smoking
Therapeutics
Counseling
Neoplasms
Outpatients
Clinical Trials

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers : A minimal intervention, randomized multicenter trial in a nonspecialized setting. / Croghan, Gary A.; Sloan, Jeff A; Croghan, Ivana T; Novotny, Paul; Hurt, Richard D.; DeKrey, Wanda L.; Mailliard, James A.; Ebbert, Larry P.; Swan, Debra K.; Walsh, Daniel J.; Wiesenfeld, Martin; Levitt, Ralph; Stella, Philip; Johnson, Patricia A.; Tschetter, Loren K.; Loprinzi, Charles Lawrence.

In: Nicotine and Tobacco Research, Vol. 5, No. 2, 04.2003, p. 181-187.

Research output: Contribution to journalArticle

Croghan, GA, Sloan, JA, Croghan, IT, Novotny, P, Hurt, RD, DeKrey, WL, Mailliard, JA, Ebbert, LP, Swan, DK, Walsh, DJ, Wiesenfeld, M, Levitt, R, Stella, P, Johnson, PA, Tschetter, LK & Loprinzi, CL 2003, 'Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting', Nicotine and Tobacco Research, vol. 5, no. 2, pp. 181-187. https://doi.org/10.1080/14622200307229
Croghan, Gary A. ; Sloan, Jeff A ; Croghan, Ivana T ; Novotny, Paul ; Hurt, Richard D. ; DeKrey, Wanda L. ; Mailliard, James A. ; Ebbert, Larry P. ; Swan, Debra K. ; Walsh, Daniel J. ; Wiesenfeld, Martin ; Levitt, Ralph ; Stella, Philip ; Johnson, Patricia A. ; Tschetter, Loren K. ; Loprinzi, Charles Lawrence. / Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers : A minimal intervention, randomized multicenter trial in a nonspecialized setting. In: Nicotine and Tobacco Research. 2003 ; Vol. 5, No. 2. pp. 181-187.
@article{a4edd1ca0e914b83a59de04fc03b25fc,
title = "Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting",
abstract = "This multicenter, randomized, open-label clinical trial was conducted to determine whether the combined use of nicotine patch therapy and a nicotine nasal spray would improve smoking abstinence rates compared to either treatment alone, without behavioral counseling. Data were collected at 15 regional cancer control oncology centers within the North Central Cancer Treatment Group. Of the 1384 smokers randomized to the study, 20{\%} were abstinent from smoking at 6 weeks and 8{\%} were abstinent at 6 months. At 6 weeks, the 7-day point prevalence smoking abstinence rate for the patch alone (21.1{\%}) was superior to the spray (13.6{\%}) but was significantly lower than the rate for combination therapy (27.1{\%}). At 6 months, the 7-day point prevalence abstinence rates were not significantly different among the three groups. Combination nicotine nasal spray and nicotine patches were delivered safely in a nonspecialized outpatient clinical setting and enhanced short-term smoking abstinence rates, but these rates were not sustained at 6 months.",
author = "Croghan, {Gary A.} and Sloan, {Jeff A} and Croghan, {Ivana T} and Paul Novotny and Hurt, {Richard D.} and DeKrey, {Wanda L.} and Mailliard, {James A.} and Ebbert, {Larry P.} and Swan, {Debra K.} and Walsh, {Daniel J.} and Martin Wiesenfeld and Ralph Levitt and Philip Stella and Johnson, {Patricia A.} and Tschetter, {Loren K.} and Loprinzi, {Charles Lawrence}",
year = "2003",
month = "4",
doi = "10.1080/14622200307229",
language = "English (US)",
volume = "5",
pages = "181--187",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers

T2 - A minimal intervention, randomized multicenter trial in a nonspecialized setting

AU - Croghan, Gary A.

AU - Sloan, Jeff A

AU - Croghan, Ivana T

AU - Novotny, Paul

AU - Hurt, Richard D.

AU - DeKrey, Wanda L.

AU - Mailliard, James A.

AU - Ebbert, Larry P.

AU - Swan, Debra K.

AU - Walsh, Daniel J.

AU - Wiesenfeld, Martin

AU - Levitt, Ralph

AU - Stella, Philip

AU - Johnson, Patricia A.

AU - Tschetter, Loren K.

AU - Loprinzi, Charles Lawrence

PY - 2003/4

Y1 - 2003/4

N2 - This multicenter, randomized, open-label clinical trial was conducted to determine whether the combined use of nicotine patch therapy and a nicotine nasal spray would improve smoking abstinence rates compared to either treatment alone, without behavioral counseling. Data were collected at 15 regional cancer control oncology centers within the North Central Cancer Treatment Group. Of the 1384 smokers randomized to the study, 20% were abstinent from smoking at 6 weeks and 8% were abstinent at 6 months. At 6 weeks, the 7-day point prevalence smoking abstinence rate for the patch alone (21.1%) was superior to the spray (13.6%) but was significantly lower than the rate for combination therapy (27.1%). At 6 months, the 7-day point prevalence abstinence rates were not significantly different among the three groups. Combination nicotine nasal spray and nicotine patches were delivered safely in a nonspecialized outpatient clinical setting and enhanced short-term smoking abstinence rates, but these rates were not sustained at 6 months.

AB - This multicenter, randomized, open-label clinical trial was conducted to determine whether the combined use of nicotine patch therapy and a nicotine nasal spray would improve smoking abstinence rates compared to either treatment alone, without behavioral counseling. Data were collected at 15 regional cancer control oncology centers within the North Central Cancer Treatment Group. Of the 1384 smokers randomized to the study, 20% were abstinent from smoking at 6 weeks and 8% were abstinent at 6 months. At 6 weeks, the 7-day point prevalence smoking abstinence rate for the patch alone (21.1%) was superior to the spray (13.6%) but was significantly lower than the rate for combination therapy (27.1%). At 6 months, the 7-day point prevalence abstinence rates were not significantly different among the three groups. Combination nicotine nasal spray and nicotine patches were delivered safely in a nonspecialized outpatient clinical setting and enhanced short-term smoking abstinence rates, but these rates were not sustained at 6 months.

UR - http://www.scopus.com/inward/record.url?scp=10744228978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744228978&partnerID=8YFLogxK

U2 - 10.1080/14622200307229

DO - 10.1080/14622200307229

M3 - Article

C2 - 12745490

AN - SCOPUS:10744228978

VL - 5

SP - 181

EP - 187

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 2

ER -